Bariatric surgery: Impact on medication management

Hospital Pharmacy

Volumn 43, Issue 2, 2008, Pages 113-120

  Sardo, Pam ^a   Walker, Jodi H ^b  

^a ABBOTT LABORATORIES   (United States)

^b VA Healthcare Network Upstate New York   (United States)

Author keywords

Bariatric surgery; Gastric; Medication

Indexed keywords

ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ADALAT CC; ADALIMUMAB; ALENDRONIC ACID; ALLEGRA D; ALPHA TOCOPHEROL; AMFEBUTAMONE; ANALGESIC AGENT; ANESTHETIC AGENT; BISACODYL; CEFAZOLIN; CIPROFLOXACIN; CITRATE CALCIUM; CLARITIN D; COCODAMOL; CODEINE; CYANOCOBALAMIN; DEPAKOTE ER; DEPAKOTE SPRINKLE; DESFLURANE; DEXMEDETOMIDINE; DEXTROPROPOXYPHENE; DILTIAZEM; ESKALITH CR; ETANERCEPT; FELODIPINE; FENTANYL; FINASTERIDE; GLIPIZIDE; HEPARIN; HERBACEOUS AGENT; HYDROCODONE BITARTRATE PLUS PARACETAMOL; INFLIXIMAB; LANSOPRAZOLE; LITHIUM CARBONATE; LOW MOLECULAR WEIGHT HEPARIN; METFORMIN; METOPROLOL SUCCINATE; MORPHINE; MORPHINE SULFATE; NIFEDIPINE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; ORAPRED; OXYCODONE; PANTOPRAZOLE; PARACETAMOL; PETHIDINE; PHENYTOIN; PIROXICAM; PREDNISOLONE; RABEPRAZOLE; RETINOL; ROXICET; SUDAFED 12 HOUR; TAMSULOSIN; ULTRAM ER; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VALPROATE SEMISODIUM; VERAPAMIL; VITAMIN D; VITAMIN K GROUP; WARFARIN;

ADOLESCENT; BARIATRIC SURGERY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG RESPONSE; DRUG WITHDRAWAL; GALLSTONE; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MORBID OBESITY; PATIENT EDUCATION; PERNICIOUS ANEMIA; POSTOPERATIVE PAIN; REVIEW; TREATMENT PLANNING; VENOUS THROMBOEMBOLISM; WEIGHT REDUCTION;

EID: 60149111049     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4302-113     Document Type: Review

References (48)

1. Johns Hopkins Medicine. The Johns Hopkins Medical Letter: Health After 50. May 2004. http://www.johnshopkinshealthalerts. com/health-after-50/main- order1.html. Accessed October 10, 2005.
2. Mattison R, Jensen MD. Bariatric surgery. Postgrad Med. 2004;115(1):49-58.
3. Beers M, Berkow R. ed. The Merck Manual of Diagnosis and Therapy, 17th ed. Merck Research Laboratories; Whitehouse Station, NJ: 1999:58-62.
4. Inova Health System. Surgical Treatment. http://www.inova.org/news/inova -fair-oaks-hospital-named-bariatric-ce nter-of-excellence.jsp?ht=. Accessed November 20, 2007.
5. American Society for Metabolic and Bariatric Surgery. Rationale for the surgical treatment of morbid obesity. http://www.asbs.org/html/patients/ rationale.html. Accessed November 20, 2007.
6. Balsiger BM, Luque de Leon E, Sarr MG. Surgical treatment of obesity: who is an appropriate candidate? Mayo Clin Proc. 1997;72(6):551-558. (Pubitemid 27330266)
7. Raymond RH. Hormonal status, fertility, and pregnancy before and after bariatric surgery. Crit Care Nurs Q. 2005;28(3):263-268. (Pubitemid 41060949)
8. Dickey RA, Bartuska DG, Bray GW, et al. AACE/ACE position statement on the prevention, diagnosis and treatment of obesity (1998 Revision). http:// www.aace.com/pub/pdf/guidelines/ obesityguide.pdf. Accessed November 20, 2007.
9. St. Peter SD, Craft RO, Tiede JL, Swain JM. Impact of advanced age on weight loss and health benefits after laparoscopic gastric bypass. Arch Surg. 2005;140(2):165-168. (Pubitemid 40229107)
10. Greenway SE, Greenway FL 3rd, Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002;137(10):1109-1117.
11. National Institutes of Health. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991; 115(12):956-961.
12. American Society for Bariatric Surgery. www.asbs.org. Accessed July 23, 2006.
13. MacGregor, A. Chapter 4: The Mason Era. Gastric bypass. http://www.midohiosurgical.com/bariatrics/ab outsurgery/surgery-story. htm#chapter4. Accessed November 20, 2007.
14. Bailey, K. Gastric bypass dumping syndrome: how to avoid it. http://www.ezinearticles.com/?Gastric-Bypass Dumping-Syndrome:-How-to-Avoid- It&id=77980. Accessed November 20, 2007.
15. Badman, MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science. 2005:307(5717): 1909-1914.
16. LeMont D, Moorehead MK, Parish MS, et al. Suggestions for the pre-surgical psychological assessment of bariatric surgery candidates. American Society for Bariatric Surgery; October 2004. http:// www.asbs.org/html/pdf/ PsychPreSur gicalAssessment.pdf. Accessed November 20, 2007.
17. Virji A, Murr MM. Caring for patients after bariatric surgery. Am Fam Physician. 2006;73(8):1403-1408.
18. Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 352(3):238-244.
19. Coumadin [package insert]. BMS; Princeton, NJ: 2005.
20. Patient and Family Education/NYU Medical Center: Laparoscopic Bariatric Surgery revised 12/2004. http://pfrc.med. nyu.edu/handouts/pdf/proced/pfrc 04-000013.pdf. Accessed July 24, 2006.
21. Premarin [package insert]. Wyeth; Philadelphia, PA: 2006.
22. Glucophage [package insert]. Bristol Myers Squibb; Princeton, NJ: 2004.
23. Schauer P, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-En Y gastric bypass on type 2 diabetes mellitis. Ann Surg. 2003;238(4):467-485. (Pubitemid 38176385)
24. Joseph B, Genaw J, Carlin A, Jordan J, Talley J, Rubinfeld I. Perioperative tight glycemic control: the challenge of bariatric surgery patients and fear of hypoglycemic events. Permanente J. 2007;11(2):36-39.
25. Edmiston CE, Krepel C, Kelly H, et al. Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels? Surgery. 2004;136(4):738-747. (Pubitemid 39311298)
26. Gonzalez QH, Tishler DS, Plata-Munoz JJ, et al. Incidence of clinically evident deep veinous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg endosc. 2004;18(7):1082-1084.
27. Feld JM, Hoffman WE, Stechert MM, Hoffman IW, Ananda RC. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18(1):24-28.
28. Maimonides Medical Center. Bariatric surgery (weight loss). http://www.maimonidesmed.org/body.cf m?id=209. Accessed September 10, 2006.
29. Dartmouth-Hitchcock Medical Center. Gastritic/gastric bypass surgery. http://www.dhmc.org/. Accessed June 26, 2006.
30. Pain Education.com. Message board for chronic pain education. http://www. pain-education.com/100202.php? V=v&msg=9999991000030001. Accessed November 19, 2007.
31. U.S. Department of Veteran's Affairs. Criteria for use of selected drugs. Meperidine. http://www.pbm.va.gov/criteria/meperidine.pdf. Accessed November 19, 2007.
32. University of Pittsburgh Medical Center. Weight management Service: bariatric surgery risks and benefits (malabsorptive Procedures). http://www.upmc.com/Services/WeightManagementServices/OurPrograms/ SurgicalWeightLoss/BenefitsandRisks/BenefitsandRisks.htm. Accessed November 19, 2007.
33. Collier K, Beard J. What a pharmacist needs to know about bariatric surgery: compounding opportunities. Inter J Pharm Comp. 2005;9(2):111-115.
34. Danbury Hospital. Center for Weight Loss Surgery at Danbury Hospital. Patient Information. http:// www.danburyhospitalcenterforweight loss.com/. Accessed November 19, 2007.
35. Wudel LJ Jr, Wright JK, Debelak JP, Allos TM, Shyr Y, Chapman WC. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002;102(1):50-56. (Pubitemid 34941252)
36. Bariatirc Surgery at Western Pennsylvania Hospital. Risks and complications of gastric bypass surgery. http://www.bariatricsurgerypittsburgh. com/surgery/risks.html#gallstones. Accessed July 23, 2006.
37. Gordon KB, Langley RG, Leonardi C, et al. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double blind, randomized controlled trial and open label extension study. J Am Acad Dermatol. 2006;55(4):598-606. (Pubitemid 44436647)
38. American Society for Metabolic and Bariatric Surgery. www.asbs.org. Accessed October 19, 2005.
39. U.S. Food and Drug Administration. Cox 2 selective and non-selective nonsteroidal anti-inflammatory drugs. http://www.fda.gov/cder/drug/infopage/c ox2/. Accessed November 19, 2007.
40. University of Pennsylvania Health System. Penn Bariatric surgery program. http://pennhealth.com/bariatrics/. Accessed November 19, 2007.
41. Gould JC, Garren MJ, Starling JR. Laparoscopic gastric bypass results in decreased prescription medication costs within 6 months. J Gastrointest Surg. 2004;8(8):983-987.
42. The American Medical Association Roadmaps on: The Treatment of Obesity. The AMA Publication on Surgical Management. Oxford University Press; New York, NY: November 2003, Booklet 7.
43. Malone M, Alger-Mayer SA. Medication use patterns after gastric bypass surgery for weight management Ann Pharmacother. 2005;39(4):637-642. (Pubitemid 40396616)
44. Potteiger CE, Paragi PR, Inverso NA, et al. Bariatric surgery: shedding the monetary weight of prescription costs in the managed care arena. Obes Surg. 2004;14(6):725-730.
45. le Roux C, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss and improve metabolic parameters. Ann Surg. 2006;243(1):108-114.
46. Beckwith MC, Feddema SS, Barton RG, Graves C. A guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. Hosp Pharm. 2004:39(3):225-237. (Pubitemid 38327385)
47. Mitchell JF, Leady MA. Oral dosage forms that should not be crushed. Hosp Pharm. 2004;39(4) issue insert. [Wall Chart].
48. Red Book, 109th ed. Montvale, NJ: Thomson Healthcare/Thomson PDR: 2005.